October 7, 2024
CGM Technology and Digital Health
CE Activities

Download a comprehensive listing of continuing education programs for pharmacists, physicians and nurses on the topic of CGM.

Learn More
Share:

September 11, 2024
CGM Technology and Digital Health
CE Activities

Program Description

Patients with diabetes who are hospitalized and have uncontrolled blood glucose levels are at a higher risk for morbidity, mortality, and health care costs. Pharmacists practicing within hospital and health-system settings can identify patients who might benefit from continuous glucose monitoring (CGM) devices. This program will outline responsibilities for health-system pharmacists to improve the integration of CGM into practice for appropriate patients. The panelists will discuss insurance coverage options, potential cost considerations, and the importance of follow-up communication with patients to address initial challenges. Panelists will share their collective experience and discuss opportunities for collaboration to ensure a smooth transition to CGM use after discharge.


Target audience: Health-system and community pharmacists

Type of activity: Application

LEARN MORE
Share:

June 12, 2024
CGM Technology and Digital Health
CE Activities

This Payer IMPACT Brief summarizes the key points of a Satellite Symposium held at the Academy of Managed Care Pharmacy 2024 Annual Meeting.

Learn More
Share:

June 3, 2024
Population Health
CE Activities

Intended Audience: This activity is designed to meet the educational needs of managed care pharmacy directors, registered nurses, clinical pharmacists, quality directors and medical directors.

Credit Available: Up to 1.0 credit hour available for nurses (ANCC), pharmacists (ACPE), and physicians (AMA PRA Category 1 Credit™)

Expiration Date:  December 31, 2025

Click here to begin!

Educational Objectives
After completing this activity, the participant should be better able to:

  • Describe recent updates to HEDIS measures in diabetes care, including opportunities associated with glucose management indicator (GMI) and an increased focus on equity
  • Describe the synergistic impact of CGM and GLP-1 agonists
  • Outline health plan best practices and strategies for streamlined coverage, access, and value of CGM

Expert Faculty

Sean Chitwood, PharmD, MBA

Clinical Pharmacist, Medicare Stars & Clinical Quality
Optum Rx

Fred Goldstein

Moderator

Accountable Health, LLC

Timothy Gilbert, MD

Clinical Endocrinologist

Imperial Health

Maureen Hennessey, PhD, CPCC, CPHQ

SVP, Director of Value Transformation

PRECISIONvalue

Susan Wescott, RPh, MBA

Senior Director of Pharmacy, Managed Care

Mayo Clinic

Jointly provided by Impact Education, LLC, and Medical Education Resources.
This continuing education activity is supported by an independent educational grant from Dexcom, Inc. Medical Affairs.

Share:

November 2, 2023
Coverage and Benefit Design
CE Activities

Intended Audience: This activity is designed to meet the educational needs of medical directors, registered nurses, pharmacy directors, clinical pharmacists, specialty pharmacists, quality directors, as well as network physicians affiliated with various MCOs, health systems, and other payer organizations.

Credit Available: Up to 0.5 credit hour available for nurses (ANCC), pharmacists (ACPE), and physicians (AMA PRA Category 1 Credit™)

Expiration Date:  April 30, 2025

Click here to begin!

Educational Objectives
After completing this activity, the participant should be better able to:

  • Describe employer/PBM coverage criteria for CGM and the clinical evidence supporting the criteria
  • Assess the challenges associated with prior authorization
  • Identify opportunities for improved access and reduced administrative burden

Expert Faculty

Janelle Grubbs, RPh

Senior Director of Clinical Services & Operations

Kroger Prescription Plans

Jeffrey Dunn, PharmD, MBA

President and CEO

Cooperative Benefits Group

Jointly provided by Impact Education, LLC, and Medical Education Resources.
This continuing education activity is supported by an independent educational grant from Dexcom, Inc. Medical Affairs.

Share:

July 14, 2023
Clinical Outcomes
CE Activities

Intended Audience: This activity is designed to meet the educational needs of medical directors, registered nurses, pharmacy directors, clinical pharmacists, specialty pharmacists, quality directors, as well as network physicians affiliated with various MCOs, health systems, and other payer organizations.

Credit Available: Up to 1.5 credit hours available for nurses (ANCC), pharmacists (ACPE), and physicians (AMA PRA Category 1 Credit™)

Expiration Date:  October 31, 2024

Click Here to Review – CE EXPIRED

Educational Objectives
After completing this activity, the participant should be better able to:

  • Assess clinical evidence and professional society guidelines for CGM systems in patients with type 1 or type 2 diabetes
  • Characterize the impact of rtCGM on clinical measures of diabetes care
  • Implement medical and pharmacy benefit design strategies to support appropriate access to rtCGM and develop evidence-based clinical criteria

Expert Faculty

Matthew D. Harman, PharmD, MPH
VP, Clinical Solutions, Employers Health

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
Endocrine Clinical Pharmacy Specialist, Co-Director, Endocrine Disorders in Pregnancy
Cleveland Clinic Endocrinology & Metabolism Institute

Gary A. Puckrein, PhD
President and Chief Executive Officer, National Minority Quality Forum

Drake Reiter, PharmD
Advisor, Pharmacy Product & Trend, Priority Health

Jointly provided by Impact Education, LLC, and Medical Education Resources.
This activity is supported by an independent educational grant from Dexcom, Inc.

Share:

March 2, 2023
Population Health
CE Activities

Intended Audience: This activity is designed to meet the educational needs of medical directors, registered nurses, pharmacy directors, clinical pharmacists, specialty pharmacists, quality directors, as well as network physicians affiliated with various MCOs, health systems, and other payer organizations.

Credit Available: Up to 0.5 credit hour available for nurses (ANCC), pharmacists (ACPE), and physicians (AMA PRA Category 1 Credit™)

Expired

Click here to review- CE Expired

Educational Objectives
After completing this activity, the participant should be better able to:

  • Describe the clinical outcomes of real-time continuous glucose monitoring initiation in insulin-treated patients with diabetes
  • Access health plan opportunities to improve diabetes outcomes for patients with diabetes based on current treatment guidelines and quality measures
  • Identify how multi-disciplinary care teams can support quality improvement interventions for patients with diabetes

Expert Faculty

Richard Dlott, MD

Managing Director

FourthFlight

Jeffrey Dunn, PharmD, MBA

Chief Clinical Officer

Cooperative Benefits Group

Jointly provided by Impact Education, LLC, and Medical Education Resources.
This continuing education activity is supported by an independent educational grant from Dexcom, Inc.

Share:

February 16, 2023
Population Health
CE Activities

Intended Audience: This activity is designed to meet the educational needs of medical directors, registered nurses, pharmacy directors, clinical pharmacists, specialty pharmacists, quality directors, as well as network physicians affiliated with various MCOs, health systems, and other payer organizations.

Credit Available: Up to 0.5 credit hour available for nurses (ANCC), pharmacists (ACPE), and physicians (AMA PRA Category 1 Credit™)

Expired

Click here to review – CE Expired

Educational Objectives
After completing this activity, the participant should be better able to:

  • Describe the risks of hypoglycemia in older patients with diabetes
  • Access health plan opportunities to identify underserved populations with diabetes, address the risks of hypoglycemia, and to implement appropriate interventions for prevention of hypoglycemia in high-risk populations
  • Identify steps for the delivery of successful quality improvement interventions in diabetes and the role of real-time continuous glucose monitoring

Expert Faculty

Estay Greene, PharmD, MBA

Vice President of Pharmacy

Zing Health

Jeffrey Dunn, PharmD, MBA

Chief Clinical Officer

Cooperative Benefits Group

Jointly provided by Impact Education, LLC, and Medical Education Resources.
This continuing education activity is supported by an independent educational grant from Dexcom, Inc.

Share:

December 20, 2022
Coverage and Benefit Design
CE Activities

Intended Audience: This activity is designed to meet the educational needs of medical directors, registered nurses, pharmacy directors, clinical pharmacists, specialty pharmacists, quality directors, as well as network physicians affiliated with various MCOs, health systems, and other payer organizations.

Credit Available: Up to 0.5 credit hour available for nurses (ANCC), pharmacists (ACPE), and physicians (AMA PRA Category 1 Credit™)

Expired

Click Here to Review – CE Expired

Educational Objectives

  • Describe the clinical impact of real-time continuous glucose monitoring on HbA1c, severe hypoglycemia-related events and diabetic ketoacidosis
  • Assess health plan opportunities to improve HbA1c and diabetes outcomes through implementation of real-time continuous glucose monitoring interventions for patients with diabetes
  • Identify key stakeholders and steps for the delivery of successful quality improvement interventions targeting patients naïve to real-time continuous glucose monitoring

Expert Faculty

Roy Gandolfi, MD

Medical Director

Select Health

Jeffrey Dunn, PharmD, MBA

Chief Clinical Officer

Cooperative Benefits Group

Jointly provided by Impact Education, LLC, and Medical Education Resources.
This continuing education activity is supported by an independent educational grant from Dexcom, Inc.

Share:

October 18, 2022
Clinical Outcomes
Coverage and Benefit Design
CE Activities
ManagedCareCGM.com Presents: The Value of Streamlined Coverage for Real-Time CGM to Optimize Outcomes and Resource Utilization for Members with Diabetes

Intended Audience: This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, registered nurses, and other managed health care professionals.

Credit Available: Up to 1.0 credit hour available for nurses (ANCC), pharmacists (ACPE), and physicians (AMA PRA Category 1 Credit™)

Expired

Click Here to Review – CE Expired

EDUCATIONAL OBJECTIVES

  • Review the latest data supporting the use of rtCGM to improve patient outcomes and reduce resource utilization in T1 and T2D
  • Assess the impact of social determinants of health (SDOH) on outcomes in diabetes among low-income and racial/ethnic minority populations
  • Describe the role of diabetes technology in increasing patient engagement and self-management across diverse member populations of varying age, race/ethnicity, income, and insurance type
  • Discuss the positive impact of electronic prior authorization for rtCGM under the pharmacy benefit in terms of provider administrative burden, access, and total cost of care

EXPERT FACULTY

Monica Peek, MD, MPH, MS
Professor of Medicine
Associate Director
Chicago Center for Diabetes Translational Research
The University of Chicago Medicine

Samir Mistry, PharmD, MBA
Vice President of Pharmacy Strategy & Services
Capital Blue Cross

Kelly Close
Founder, The diaTribe Foundation
President, Close Concerns

Dana McCormick, RPh, FMACP (Moderator)
Director of Pharmacy
Blue Cross Blue Shield of Texas

Jointly provided by Impact Education, LLC, and Medical Education Resources.
This continuing education activity is supported by an independent educational grant from Dexcom, Inc.

Share:

  • 1
  • 2
  • 1-10 of 11 results